RNA Manufacturing Solutions

1. A Ready-To-Use, Single-Use Liquid Chromatography System 5/13/2024

   The ÄKTA ready™ system family consists of a range of single-use liquid chromatography hardware options that are built for process scale-up and manufacturing. The systems operate with ready‑to‑use, disposable flow paths that are available in two sizes for each system option — high or low flow — providing a wide operating flow rate range.

2. mRNA/LNP Development And Manufacturing Services

   Messenger RNAs (mRNAs) represent a fast-emerging class of biotherapeutics. In recent years, we at Lonza have amassed considerable expertise in the commercial manufacturing of mRNA and its encapsulation in Lipid Nanoparticles (LNP) at cGMP quality.

3. Revolutionizing Pharmaceutical Purification: Advanced Compound Processing 2/6/2025

   Discover enhanced pharmaceutical manufacturing with automated HPLC for peptide and small molecule purification, featuring robust controls, high-performance capabilities, and compliance with regulatory standards.

4. Biologics Manufacturing 5/15/2024

   ReciBioPharm GMP manufacturing units focus on process robustness and consistency to ensure product quality, purity and efficacy. Our multi-product manufacturing facilities feature state-of-the-art equipment for animal cell-derived viral and microbial products for your clinical trials in phase 1-2 and in accordance with cGMP guidelines.

5. UNICORN™ Control Chromatography System 6/5/2024

   UNICORN™ control software offers real-time control of protein purification unit operations (column packing and chromatography) from laboratory bench, through development, to full-scale production. UNICORN™ control system meets the needs of full-scale production with manufacturing systems while maintaining the flexibility needed for method and process development with the range of systems in the ÄKTA™ family.

6. Your Vision. Our Pioneering Experience. 3/10/2021

   PRECISION ADVANCE, a collection of interconnected services and complementary teams, uniquely focuses on the complexities of clinical, regulatory, manufacturing, and commercial needs to successfully bring cell or gene therapies to market.

7. Modular Environments For Biomanufacturing Capacity 9/16/2024

   Accelerate your biomanufacturing capacity with purpose-built modules

   KUBio™ box modular bioprocessing environments are designed to help biopharmaceutical manufacturers bring high-quality biopharmaceuticals to market more quickly. By reducing typical design and construction times and streamlining process execution, they support future expansion and replication needs. Available KUBio™ box modular environments for biosafety levels 1 and 2 (BSL-1 and BSL-2) can be delivered in 10 to 15 months for implementation inside existing infrastructure. The result? Reduced project risk, accelerated delivery of next-gen therapies, and greater flexibility at different production scales and product technologies.

8. Brochure: The Power Of Small: Nanoplasmid™ Vector Platform 1/19/2023

   With gene therapy advancing at a record pace, Aldevron recognizes the enormous promise your work can bring to therapeutics. We are proud to deliver a superior, modern plasmid technology to your therapeutic endeavors.

9. A Disruptive Technology Accelerating Drug Development 7/1/2022

   Ignite simplifies the transition into clinical programs by incorporating these fundamental process steps for scale up in the earliest stages of pre-clinical development.

    

10. Pre-GMP mRNA And LNP Development 11/26/2024

    Leverage Pre-GMP mRNA and LNP development services to streamline process development, mitigate risks early, and accelerate your path to market with high-quality, compliant drug products.